Contrary to a prior study that claimed a higher number of FOXP3+ T-regulatory cells in early than in the advanced MF stage, and linked them to a favorable clinical outcome [20], no association was observed between their percentage and MF stage in our series. This evidence concerns the gene FOXP3 and mycosis fungoides.